Eric Lefkofsky’s Tempus, a cancer fighting startup, is looking to give data to doctors at the University of Chicago. The goal is to provide better treatment to patients with breast cancer.
Two months ago Tempus, based in Chicago, announced it has partnered with the University of Chicago Medicine. The partnership will involve providing the university with molecular sequencing and analysis to breast cancer specialists at the university. The goal is to create personalized treatments to patients. The company plans on analyzing around 1,000 patients to help researchers and doctors find patterns that can predict how breast cancer patients will respond to treatment and more information click here.
Doctor Olufunmilayo Olopade, who is a professor of medicine and human genetics, said breast cancer is one of the most common forms of cancer. He added said that even though that’s the case, there’s not that much accessible data on the millions of people who have battled breast cancer.
He added that this forces doctors to make decisions without certain genetic info, which could be beneficial to know. This is because doctors would be able to make better decisions. He finished by saying the university was excited to partner with Tempus and learn more about Eric.
About Eric Lefkofsky
Eric Lefkofksy is the CEO of the cancer fighting startup Tempus. Not only did he co-found the startup, but he is also the co-founder of one of the most popular marketplaces, Groupon. The businessman co-founded Lightbank, as well as Uptake Technologies.
The businessman established a charitable foundation called the Lefkofsky Family Foundation. He founded the foundation alongside his wife and since 2006 it has been involved with initiatives that help improve lives in the communities the foundation serves.
Eric Lefkofsky is a Trustee at various institutions, such as the Art Institute of Chicago, the Lurie Children’s Hospital and the Museum of Science and Industry and World Business.